A progressive step was made this November towards taking action against
birth control products containing drospirenone. A judge in the Southern
District of Illinois has allowed 10 documents to be classified in the
petition against the drug company that makes
Yaz and Yasmin products
(Bayer) to the FDA. This is a movement that is pushing for drugs that
have drospirenone in them to be labeled with a warning or be restricted.
It should be noted that Bayer did not contest the plaintiff's right
to petition the FDA.
Our firm is litigating many cases, including two "bellwether" cases in
New Jersey state court, also known as lead cases. We have access to experts
and litigation documents to prepare us for litigation against Bayer.
